sulfasalazine has been researched along with Kidney Diseases in 14 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 29-year-old male patient with ulcerative colitis, who underwent haemodialysis thrice a week because of severe renal dysfunction." | 1.32 | Sulphasalazine-induced leucopenia in a patient with renal dysfunction. ( Hino, B; Iida, M; Itoh, Y; Joh, Y; Makino, K; Oishi, R; Teshima, D; Yano, T, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (21.43) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 8 (57.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmadi, A | 1 |
| Niknahad, H | 1 |
| Li, H | 1 |
| Mobasheri, A | 1 |
| Manthari, RK | 1 |
| Azarpira, N | 1 |
| Mousavi, K | 1 |
| Khalvati, B | 1 |
| Zhao, Y | 1 |
| Sun, J | 1 |
| Zong, Y | 1 |
| Ommati, MM | 1 |
| Heidari, R | 1 |
| Cámara-Lemarroy, CR | 1 |
| Guzmán-de la Garza, FJ | 1 |
| Alarcón-Galván, G | 1 |
| Cordero-Pérez, P | 1 |
| Fernández-Garza, NE | 1 |
| Teshima, D | 1 |
| Hino, B | 1 |
| Makino, K | 1 |
| Yano, T | 1 |
| Itoh, Y | 1 |
| Joh, Y | 1 |
| Iida, M | 1 |
| Oishi, R | 1 |
| Logan, RF | 1 |
| van Staa, TP | 1 |
| Sugii, S | 1 |
| Tugcu, V | 1 |
| Ozbek, E | 1 |
| Tasci, AI | 1 |
| Kemahli, E | 1 |
| Somay, A | 1 |
| Bas, M | 1 |
| Karaca, C | 1 |
| Altug, T | 1 |
| Cekmen, MB | 1 |
| Ozdogan, HK | 1 |
| Takeyama, J | 1 |
| Umebayashi, H | 1 |
| Inagaki, T | 1 |
| Janowitz, HD | 1 |
| Sachar, DB | 1 |
| Kreisel, W | 1 |
| Wolf, LM | 1 |
| Grotz, W | 1 |
| Grieshaber, M | 1 |
| Hidaka, M | 1 |
| Ohsawa, I | 1 |
| Endo, M | 1 |
| Fujita, T | 1 |
| Ohi, H | 1 |
| Kanmatsuse, K | 1 |
| Kusumi, Y | 1 |
| Yamaguchi, Y | 1 |
| Birketvedt, GS | 1 |
| Berg, KJ | 1 |
| Fausa, O | 1 |
| Florholmen, J | 1 |
| Wali, RK | 1 |
| Henrich, WL | 1 |
| Matuchansky, C | 1 |
| Blackstone, MO | 1 |
3 reviews available for sulfasalazine and Kidney Diseases
| Article | Year |
|---|---|
[Adverse effects of DMARDs in treatment of rheumatoid arthritis].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Female; Gold Sodium Thiomalate; Hematologic Diseases; H | 2005 |
Inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Adult; Child; Colectomy; Colitis, Ulcerative; Crohn Disease; Female; Humans | 1982 |
Recent developments in toxic nephropathy.
Topics: Antifungal Agents; Antiretroviral Therapy, Highly Active; Cyclooxygenase 2; Cyclooxygenase 2 Inhibit | 2002 |
11 other studies available for sulfasalazine and Kidney Diseases
| Article | Year |
|---|---|
The inhibition of NFкB signaling and inflammatory response as a strategy for blunting bile acid-induced hepatic and renal toxicity.
Topics: Animals; Anti-Inflammatory Agents; Cholestasis; Common Bile Duct; Cytokines; Disease Models, Animal; | 2021 |
Effect of sulfasalazine on renal ischemia/reperfusion injury in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Kidney Diseases; Male; NF- | 2009 |
Sulphasalazine-induced leucopenia in a patient with renal dysfunction.
Topics: Adult; Arylamine N-Acetyltransferase; Colitis, Ulcerative; Gastrointestinal Agents; Humans; Kidney D | 2003 |
Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines.
Topics: Adverse Drug Reaction Reporting Systems; Anti-Inflammatory Agents, Non-Steroidal; Data Interpretatio | 2003 |
Selective nuclear factor kappa-B inhibitors, pyrolidium dithiocarbamate and sulfasalazine, prevent the nephrotoxicity induced by gentamicin.
Topics: Animals; Gentamicins; I-kappa B Proteins; Immunohistochemistry; Kidney Diseases; Male; NF-kappa B; N | 2006 |
Renal involvement in a patient with juvenile idiopathic arthritis presenting after treatment for Hodgkin lymphoma.
Topics: Arthritis, Juvenile; Child; Drug Therapy, Combination; Epstein-Barr Virus Infections; Female; Hematu | 2007 |
Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, N | 1996 |
[Beneficial effect of salazosulfapyridine (SASP) in a patient with secondary renal amyloidosis].
Topics: Amyloidosis; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Female; Humans; Kidney | 1998 |
Glomerular and tubular renal functions after long-term medication of sulphasalazine, olsalazine, and mesalazine in patients with ulcerative colitis.
Topics: Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Female; Gastrointestinal Agents; Humans; Kid | 2000 |
Inflammatory bowel diseases 1977.
Topics: Azathioprine; Colitis, Ulcerative; Crohn Disease; Cromolyn Sodium; Diet; Eye Diseases; Humans; Joint | 1977 |
Hypersensitivity reaction to sulfasalazine--two reports of the same patient.
Topics: Adult; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity; Female; Humans; Kidney Disease | 1978 |